Table 2.
Study gel | Parity | Median | Range | p- Wilcoxon |
---|---|---|---|---|
Placebo | Nullip | 7 | 2–10 | < 0.01 |
Parous | 5 | 0–9 | ||
Lidocaine | Nullip | 6 | 2–10 | 0.01 |
Parous | 4 | 1–10 |
Study gel | Parity | Median | Range | p- Wilcoxon |
---|---|---|---|---|
Placebo | Nullip | 7 | 2–10 | < 0.01 |
Parous | 5 | 0–9 | ||
Lidocaine | Nullip | 6 | 2–10 | 0.01 |
Parous | 4 | 1–10 |